5//SEC Filing
ORAGENICS INC 5
Accession 0000899243-16-013112
$OGENCIK 0001174940operating
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:08 PM ET
Size
20.8 KB
Accession
0000899243-16-013112
Insider Transaction Report
Form 5
ORAGENICS INCOGEN
KOSKI FAMILY LP
10% Owner
Transactions
- Gift
Common Stock
2015-02-02−1,362,527→ 8,257,742 total(indirect: By KFLP) - Other
Common Stock
2015-12-13−1,208,000→ 7,049,742 total - Other
Common Stock
2015-12-13+400,000→ 1,552,523 total - Other
Common Stock
2015-12-13+200,000→ 967,878 total - Other
Common Stock
2015-12-13+400,000→ 919,666 total - Other
Common Stock
2015-12-13+8,000→ 28,000 total(indirect: By Koski Manage-ment, Inc.)
Holdings
- 530,851(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]Robert C. Koski gifted half of his Koski Family Limited Partnership ("KFLP") limited partnership interests constituting 16.5% of KFLP ownership interests in the shares, to five separate irrevocable trusts for the benefit of his children, for which Mr. Koski does not serve as trustee (the "RCK Irrevocable Trusts"). Mr. Koski disclaims beneficial ownership of the shares.
- [F2]Shares owned directly by KFLP. On December 13, 2015, the Koski Family Limited Partnership ("KFLP") distributed 1,208,000 shares of Oragenics, Inc. common stock to the KFLP's underlying general and limited partners on a pro rata basis in accordance with their ownership interests in the KFLP as follows: Beverly Koski (through Koski Management, Inc.) (8,000); Christine L. Koski 400,000); Thomas L. Koski (400,000); Robert C. Koski; (200,000); and the RCK Irrevocable Trusts (200,000) of which neither the KFLP nor any of its general partners serve as trustees.
- [F3]The shares are indirectly beneficially owned by each of the KFLP's general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski. Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F4]Shares owned directly by Christine L. Koski, a director of the Company.
- [F5]Shares owned directly by Robert C. Koski, a director of the Company.
- [F6]Shares owned directly by Thomas L. Koski.
- [F7]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
- [F8]Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001174940
Filing Metadata
- Form type
- 5
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:08 PM ET
- Size
- 20.8 KB